Peter Lin MD, CCFP
Director, Primary Care Initiatives, Canadian Heart Research Centre, North York, OntarioDr. Peter Lin, a primary care physician, is the Director of Primary Care Initiatives at the Canadian Heart Research Centre and has two busy family medicine practices in Toronto. For 7 years, he served as the medical director at the University of Toronto Scarborough Health & Wellness Centre. In 2011, he received a teaching award from the College of Family Physicians of Canada.
Dr. Lin has worked with KDIGO (Kidney Disease│Improving Global Outcomes) in an effort to help enhance care for patients with chronic kidney disease. He has been a contributing author to the Canadian Diabetes Guidelines and has served on the editorial board of Pri-Med Institute, which provides education for physicians.
Dr. Lin maintains an active lecture schedule, reflecting his varied medical interests, continuing his focus on bridging the chasm between research and clinical practice.
Disclosures
- Consultant (continuing medical education programs): AstraZeneca; Boehringer Ingelheim; Bayer; Eli Lilly; Amgen; Janssen; Merck; Pfizer; Sanofi; Abbott; HLS Therapeutics
Recent Contributions to PracticeUpdate:
- Glycemic Control in Older Adults With Diabetes Mellitus
- Stroke Risk Factors Beyond the CHA2DS2-VASc Score: Can We Improve Our Identification of "High Stroke Risk" Patients With Atrial Fibrillation?
- Risks of β-Blocker Use in Noncardiac Surgery
- Risk for Cardiovascular Events Across Blood Pressure Levels
- Review of Adverse Effects of Smoke Exposure on the Autonomic Nervous System
- Reducing Risk of Cardiovascular Disease in Type 2 Diabetics
- Meta-Analysis Comparing the Effects of Rosuvastatin vs Atorvastatin on Regression of Coronary Atherosclerotic Plaques
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- Glyburide Use Found to Increase Cancer Risk in Type 2 Diabetes
- In-Flight Medical Emergencies During Commercial Travel